FKBP12-binding domain analogues of FK506 are potent, nonimmunosuppressive neurotrophic agents in vitro and promote recovery in a mouse model of parkinson's disease
- 8 July 1997
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 7 (13) , 1785-1790
- https://doi.org/10.1016/s0960-894x(97)00304-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin ANature Medicine, 1997
- The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerveJournal of Neuroscience, 1995
- RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORsCell, 1994
- A mammalian protein targeted by G1-arresting rapamycin–receptor complexNature, 1994
- The immunosuppressant FK506 increases functional recovery and nerve regeneration following peripheral nerve injuryRestorative Neurology and Neuroscience, 1994
- High brain densities of the immunophilin FKBP colocalized with calcineurinNature, 1992
- Atomic structure of the rapamycin human immunophilin FKBP-12 complexJournal of the American Chemical Society, 1991
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991
- Atomic Structure of FKBP-FK506, an Immunophilin-Immunosuppressant ComplexScience, 1991
- Chemistry and Biology of the Immunophilins and Their Immunosuppressive LigandsScience, 1991